Related Experiment Video
Updated: Mar 25, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Statins and Cognitive Side Effects: What Cardiologists Need to Know
Carlos Rojas-Fernandez1, Zain Hudani2, Vera Bittner3
1Schlegel-UW Research Institute for Ageing & School of Pharmacy, University of Waterloo, Waterloo, Ontario, Canada; School of Public Health and Health Systems, Faculty of Applied Health Sciences, University of Waterloo, Waterloo, Ontario, Canada; Michael G. DeGroote School of Medicine, Department of Family Medicine, McMaster University, Hamilton, Ontario, Canada.
Insights
Statins effectively prevent cardiovascular disease with a good safety profile. While some reports suggest cognitive side effects, current evidence indicates they should not deter statin use for most patients.
Area of Science:
- Cardiology
- Neurology
- Pharmacology
Background:
- Statins are primary and secondary prevention agents for atherosclerotic cardiovascular disease.
- They significantly reduce cardiovascular events and mortality.
- Statins are generally considered safe, but recent reports link them to cognitive adverse effects.
Purpose of the Study:
- To review current literature on statins and cognitive function.
- To provide clinical recommendations regarding statin use and cognition.
Main Methods:
- Literature review of recent studies on statins and cognition.
- Analysis of case reports and clinical trial data.
Main Results:
- Most evidence does not support a significant negative impact of statins on cognition.
- Cognitive concerns are not a primary reason to withhold statin therapy for indicated patients.
Conclusions:
- Cognitive effects should not generally influence the decision to prescribe statins.
- Future clinical trials should incorporate systematic cognitive assessments for lipid-lowering agents.
Abstract:
Statins are widely used in secondary and primary prevention of atherosclerotic cardiovascular disease. They reduce cardiovascular events and mortality, and have an excellent safety record. Recent case reports suggest a possible association between statins and adverse effects on cognition. This article reviews recent literature related to statins and cognition and provides recommendations to clinicians. Cognitive considerations should not play a role in decision making for most patients for whom statins are indicated. Future trials of statin, or any novel antilipemic agent should include systematic assessment of cognition.
More Related Videos
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Alzheimer's Disease: Treatment
Anxiolytic Drugs: Benzodiazepines and Buspirone
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...

